"During my time at Fox Chase, I have established the influenza infection model, which, combined with conventional molecular methods, elucidated the mechanisms in which influenza infected cells activate a parallel cell death pathways as a host defense method."
Dr. Vijayvergia has been a faculty member of Fox Chase since 2015. She also serves as assistant professor in the department of hematology/oncology as well as the assistant chief of gastrointestinal medical oncology.
I am the product of a blue-collar upbringing. I was raised on the principles of working hard and getting an education, but without funding from the National Institute of Health (NIH), I wouldn’t have had the opportunity to pursue scientific research.
"The current phase of my career began serendipitously when I met Dr. Roland Dunbrack in India. I became his tour guide and we spoke about everything from culture and history, to science, which led to me becoming a postdoc in his lab in December 2013."
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere, such a phase 3 clinical trial for MSI-H or dMMR colorectal cancer.